VELANS AI develops pharmacokinetic and pharmacodynamic software for individualising dosage regimens of narrow-therapeutic-index drugs — a line of development begun in 1990.
Derive rather than assume. Report the interval rather than the point estimate. State the limitations alongside the result. Record a falsification when the data refutes an assumption. A number changes the odds; it does not settle the outcome — and the uncertainty is attached rather than stripped.
The work spans clinical decision support for narrow-therapeutic-index medicine and applied methodological demonstrations.
Founded and led by Dr. D. C. Sundaravelan — Independent Researcher, Educator, and pharmacometric software developer, Coimbatore.